Skip to main content

ADVERTISEMENT

laser

Original Contribution
05/11/2022
The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...
The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...
The Auryon 355-nm laser...
05/11/2022
Journal of Invasive Cardiology
Original Contribution
03/15/2018
We examined the baseline clinical and angiographic characteristics and procedural outcomes of 130 target lesions in 121 consecutive PCIs (n = 116 patients) in which excimer laser coronary atherectomy was performed at three United States...
We examined the baseline clinical and angiographic characteristics and procedural outcomes of 130 target lesions in 121 consecutive PCIs (n = 116 patients) in which excimer laser coronary atherectomy was performed at three United States...
We examined the baseline...
03/15/2018
Journal of Invasive Cardiology